🚨 NEW: CEPI has launched an additional Call for Proposals in response to the current Bundibugyo virus (BDBV) outbreak in the DRC and Uganda to support critical, time-sensitive activities that directly inform and support vaccine R&D decision-making. Two workstreams are in scope: 🔵 Epidemiology, modelling and analytics 🔵 Immunological and clinical assessment of potential cross-reactive antibodies induced by existing Ebola vaccines. The Call is open to global applicants; special consideration will be given to proposals from, or partnering with, groups based in Africa. ➡️ Read the full text to find out more, including eligibility criteria and how to apply via the CEPI Portal: cepi.my.site.com/calls-for-p… Deadline: 22 June 2026. This Call is complementary to CEPI’s other Call for Proposals, which is seeking to urgently accelerate the development of BDBV vaccine candidates. Please consider sharing among your networks.

“It is not clear how many doses of MBP-134 exist at present. STAT asked the company and was told Mapp Bio could not reveal the number because BARDA owned the doses” statnews.com/2026/06/04/keny…

Democratic Republic of Congo said on Friday that 71 new Ebola cases were confirmed in a 24-hour period and warned of rapid community transmission of the deadly disease. reuters.com/business/healthc…

Cases of Ebola are thankfully rare in the UK, but healthcare services must be prepared to assess and care for patients in whom Ebola is a possibility. This message summarises what to do and how to prepare, ensuring safe care whilst minimising disruption. gov.uk/guidance/ebola-diseas…

How health workers in DR Congo are treating Ebola and staying safe bbc.in/49AZ3b8

Ebola is a terrible disease because you often catch it while caring for someone you love – a husband, a child, a mother. Stopping transmission means helping communities recognize symptoms early, access testing quickly and get timely care.

This is interesting & gets at a real challenge of how to tell if things are working in real time We proposed 2 metrics (% cases from known chains & symptom-to-isolation interval) that never caught on & don’t get reported like confirmed/suspect cases do thelancet.com/journals/lance…

Pleased to have contributed to this session. I talked about preparing to care for suspected & rare confirmed cases of Ebola in Europe, focussing on key principles & proportionate measures to manage any potential infection risk, without causing panic or disrupting other services.

Can mosquitoes learn to love DEET? 🦟 Research published yesterday suggests that mosquitoes may learn to associate the smell of DEET with dinner—and start gravitating toward it instead of away from it. Read more: ow.ly/2bCM50Z5JSV

Failure to fund an effective, rapid response now risks the same higher-wealth countries & regions having to pay out a lot more later to manage this crisis, potentially including managing related risks closer to home. The burden should not fall on just a few countries & charities.

Sounds like a great initiative. Would be good to know what the risk assessment is for exposure to pathogens in the air, including Legionella risk from cooling towers etc. And also how risk (including particulate/chem exposure) from 'roof-top air' compares to that for air in ICU.

We spoke to WHO's Dr Marie Belizaire from Bunia, Ituri province, Eastern DRC who told us that out of 2500 ebola suspected contacts that they needed to trace only 30% had been located because of insecurity in the region. #FocusOnAfrica @BBCAfrica

Again, those calling for community masking, perhaps because they think all infectious diseases are the same, need a wake up call about how Ebola transmits and the challenges of preventing contact transmission in resource-limited settings where even hand-washing can be difficult.

Establishing an efficient & effective end-to-end pathway for BDBV testing, from sample collection to reporting results (whether ve or -ve) must be a key priority in response efforts. Many challenges, so also need contingency plans & mitigations for this being slower than hoped.

This is good news.

Facemasks do not prevent spread of Ebola virus in affected communities. Ebola transmits between humans through contact with an infected person's body fluids and excreta, or an environment they have contaminated. It is not a respiratory disease. 'A cavalier attitude' is misplaced.